[Corrections] Correction to Lancet Oncol 2018; 19: 295–309

de Boer SM, Powell ME, Mileshkin L, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 2018; 19: 295–309—In this Article, the Open Access licence has been changed from CC-BY-NC-ND to CC BY. This correction has been made to the online version as of March 28,2018.

https://ift.tt/2pLx96u